Journal Home > Volume 2 , Issue 5

menu
Full text
Outline
About this article

The road toward breast cancer single‐disease quality control in China

Show Author's information Bo LanQiao LiFei Ma ( )Binghe Xu( )
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Keywords: quality control, breast cancer, China

References(4)

1

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660

2

Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, et al. Changing cancer survival in China during 2003‐15: a pooled analysis of 17 population‐based cancer registries. Lancet Global Health. 2018;6(5):e555–67. https://doi.org/10.1016/S2214-109X(18)30127-X

3

Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J. 2021;134(7):783–91. https://doi.org/10.1097/CM9.0000000000001474

4

Breast Cancer Expert Committee of National Cancer Quality Control. Quality control index for standardized diagnosis and treatment of breast cancer in China (2022 Edition). Zhonghua Zhong Liu Za Zhi [Chinese J Oncol]. 2022;44(3):203–8. https://doi.org/10.3760/cma.j.cn112152-20220104-00008

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Published: 01 September 2023
Issue date: October 2023

Copyright

© 2023 The Authors. Tsinghua University Press.

Acknowledgements

ACKNOWLEDGMENTS

None.

Rights and permissions

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Return